Search research articles
Contact Us
Filters
Showing results (21-30 of 41) with videos related to
Page
of 5
Sort By:
Zeitschrift Fur Gastroenterologie
|
July 19, 2011
[Pharmacotherapy in patients with ulcerative colitis]
M Scherer, J Hardt, E Blozik, et al.
Alimentary Pharmacology & Therapeutics
|
May 31, 2016
Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study
C Schmidt, T Ahmad, Z Tulassay, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 13, 2014
[Evolution of biologicals in inflammation medicine--biosimilars in gastroenterology, rheumatology and dermatology]
S Schreiber, T Luger, T Mittendorf, et al.
Hepato-Gastroenterology
|
December 1, 1990
Epidemiology and treatment of gastric Campylobacter pylori infection: more questions than answers
R Iserhard, J Freise, S Wagner, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 27, 1989
[Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin]
B Bokemeyer, R Grote, E Schmoll, et al.
Zeitschrift Fur Gastroenterologie
|
May 29, 2015
[Current position on Vedolizumab for ulcerative colitis and Crohn's disease]
S Schreiber, A U Dignass, H Hartmann, et al.
International Journal of Colorectal Disease
|
May 20, 2020
Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting
B Bokemeyer, M Ghiani, A Fuchs, et al.
Journal of Crohn'S & Colitis
|
May 10, 2017
Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence
S Nikolaus, S Schreiber, B Siegmund, et al.
Journal of Crohn'S & Colitis
|
November 28, 2012
Predictive factors for an uncomplicated long-term course of Crohn's disease: a retrospective analysis
W Kruis, A Katalinic, T Klugmann, et al.
Zeitschrift Fur Gastroenterologie
|
October 7, 2016
[Biosimilars in inflammatory bowel disease]
B Siegmund, R Atreya, B Bokemeyer, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 41) with videos related to
Sort By:
Page
of 5
Zeitschrift Fur Gastroenterologie
|
July 19, 2011
[Pharmacotherapy in patients with ulcerative colitis]
M Scherer, J Hardt, E Blozik, et al.
Alimentary Pharmacology & Therapeutics
|
May 31, 2016
Ferric maltol therapy for iron deficiency anaemia in patients with inflammatory bowel disease: long-term extension data from a Phase 3 study
C Schmidt, T Ahmad, Z Tulassay, et al.
Deutsche Medizinische Wochenschrift (1946)
|
November 13, 2014
[Evolution of biologicals in inflammation medicine--biosimilars in gastroenterology, rheumatology and dermatology]
S Schreiber, T Luger, T Mittendorf, et al.
Hepato-Gastroenterology
|
December 1, 1990
Epidemiology and treatment of gastric Campylobacter pylori infection: more questions than answers
R Iserhard, J Freise, S Wagner, et al.
Deutsche Medizinische Wochenschrift (1946)
|
January 27, 1989
[Chemoembolization of hepatocellular carcinoma with lipiodol, epirubicin and cisplatin]
B Bokemeyer, R Grote, E Schmoll, et al.
Zeitschrift Fur Gastroenterologie
|
May 29, 2015
[Current position on Vedolizumab for ulcerative colitis and Crohn's disease]
S Schreiber, A U Dignass, H Hartmann, et al.
International Journal of Colorectal Disease
|
May 20, 2020
Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting
B Bokemeyer, M Ghiani, A Fuchs, et al.
Journal of Crohn'S & Colitis
|
May 10, 2017
Patient Education in a 14-month Randomised Trial Fails to Improve Adherence in Ulcerative Colitis: Influence of Demographic and Clinical Parameters on Non-adherence
S Nikolaus, S Schreiber, B Siegmund, et al.
Journal of Crohn'S & Colitis
|
November 28, 2012
Predictive factors for an uncomplicated long-term course of Crohn's disease: a retrospective analysis
W Kruis, A Katalinic, T Klugmann, et al.
Zeitschrift Fur Gastroenterologie
|
October 7, 2016
[Biosimilars in inflammatory bowel disease]
B Siegmund, R Atreya, B Bokemeyer, et al.
Page
of 5